ACUT
Price
$0.90
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
14.47M
IGMS
Price
$1.36
Change
+$0.04 (+3.03%)
Updated
Jul 3 closing price
Capitalization
81.86M
35 days until earnings call
Interact to see
Advertisement

ACUT vs IGMS

Header iconACUT vs IGMS Comparison
Open Charts ACUT vs IGMSBanner chart's image
Accustem Sciences
Price$0.90
Change-$0.00 (-0.00%)
Volume$37.67K
Capitalization14.47M
IGM Biosciences
Price$1.36
Change+$0.04 (+3.03%)
Volume$526.79K
Capitalization81.86M
ACUT vs IGMS Comparison Chart in %
Loading...
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACUT vs. IGMS commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUT is a Hold and IGMS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (ACUT: $0.90 vs. IGMS: $1.36)
Brand notoriety: ACUT and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACUT: 932% vs. IGMS: 93%
Market capitalization -- ACUT: $14.47M vs. IGMS: $81.86M
ACUT [@Biotechnology] is valued at $14.47M. IGMS’s [@Biotechnology] market capitalization is $81.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACUT’s FA Score shows that 1 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • ACUT’s FA Score: 1 green, 4 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, ACUT is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACUT’s TA Score shows that 4 TA indicator(s) are bullish while IGMS’s TA Score has 4 bullish TA indicator(s).

  • ACUT’s TA Score: 4 bullish, 4 bearish.
  • IGMS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACUT is a better buy in the short-term than IGMS.

Price Growth

ACUT (@Biotechnology) experienced а +1.58% price change this week, while IGMS (@Biotechnology) price change was +11.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.35%. For the same industry, the average monthly price growth was +13.82%, and the average quarterly price growth was -0.82%.

Reported Earning Dates

IGMS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IGMS($81.9M) has a higher market cap than ACUT($14.5M). ACUT YTD gains are higher at: 100.893 vs. IGMS (-77.741). ACUT has higher annual earnings (EBITDA): -1.42M vs. IGMS (-178.4M). IGMS has more cash in the bank: 152M vs. ACUT (36.4K). ACUT has less debt than IGMS: ACUT (57.6K) vs IGMS (44M). IGMS has higher revenues than ACUT: IGMS (2.68M) vs ACUT (0).
ACUTIGMSACUT / IGMS
Capitalization14.5M81.9M18%
EBITDA-1.42M-178.4M1%
Gain YTD100.893-77.741-130%
P/E RatioN/AN/A-
Revenue02.68M-
Total Cash36.4K152M0%
Total Debt57.6K44M0%
TECHNICAL ANALYSIS
Technical Analysis
ACUTIGMS
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
66%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
79%
MACD
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
83%
Aroon
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MDIBY21.830.01
+0.07%
MedioBanca SpA
ACMDY1.35N/A
N/A
Atlas Consolidated Mining & Development Corp.
BGAOY1.91N/A
N/A
Proximus Group
HAWEL15.24N/A
N/A
Hawaiian Electric Co., Inc.
ROOOF0.26N/A
-0.75%
NORTHSTAR CLEAN TECHNOLOGIES INC.

ACUT and

Correlation & Price change

A.I.dvisor tells us that ACUT and LGVN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACUT and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACUT
1D Price
Change %
ACUT100%
N/A
LGVN - ACUT
30%
Poorly correlated
+0.77%
OKYO - ACUT
28%
Poorly correlated
-4.47%
IGMS - ACUT
21%
Poorly correlated
+3.03%
APVO - ACUT
20%
Poorly correlated
N/A
VRNA - ACUT
20%
Poorly correlated
+1.61%
More

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+3.03%
MRSN - IGMS
56%
Loosely correlated
+3.50%
CRNX - IGMS
49%
Loosely correlated
+1.22%
DYN - IGMS
47%
Loosely correlated
-2.01%
APGE - IGMS
43%
Loosely correlated
+7.08%
APLS - IGMS
43%
Loosely correlated
+2.47%
More